1
|
Bayard C, Segna E, Taverne M, Fraissenon A, Hennocq Q, Periou B, Zerbib L, Ladraa S, Chapelle C, Hoguin C, Kaltenbach S, Villarese P, Asnafi V, Broissand C, Nemazanyy I, Autret G, Goudin N, Legendre C, Authier FJ, Viel T, Tavitian B, Gitiaux C, Fraitag S, Duong JP, Delcros C, Sergent B, Picard A, Dussiot M, Guibaud L, Khonsari R, Canaud G. Hemifacial myohyperplasia is due to somatic muscular PIK3CA gain-of-function mutations and responds to pharmacological inhibition. J Exp Med 2023; 220:e20230926. [PMID: 37712948 PMCID: PMC10503430 DOI: 10.1084/jem.20230926] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2023] [Revised: 07/19/2023] [Accepted: 08/09/2023] [Indexed: 09/16/2023] Open
Abstract
Hemifacial myohyperplasia (HFMH) is a rare cause of facial asymmetry exclusively involving facial muscles. The underlying cause and the mechanism of disease progression are unknown. Here, we identified a somatic gain-of-function mutation of PIK3CA in five pediatric patients with HFMH. To understand the physiopathology of muscle hypertrophy in this context, we created a mouse model carrying specifically a PIK3CA mutation in skeletal muscles. PIK3CA gain-of-function mutation led to striated muscle cell hypertrophy, mitochondria dysfunction, and hypoglycemia with low circulating insulin levels. Alpelisib treatment, an approved PIK3CA inhibitor, was able to prevent and reduce muscle hypertrophy in the mouse model with correction of endocrine anomalies. Based on these findings, we treated the five HFMH patients. All patients demonstrated clinical, esthetical, and radiological improvement with proof of target engagement. In conclusion, we show that HFMH is due to somatic alteration of PIK3CA and is accessible to pharmacological intervention.
Collapse
Affiliation(s)
- Charles Bayard
- Université Paris Cité, Paris, France
- Institut national de la santé et de la recherche médicale U1151, Institut Necker-Enfants Malades, Paris, France
- Unité de Médecine Translationnelle et Thérapies Ciblées, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Eleonora Segna
- Service De Chirurgie Maxillo-Faciale et Chirurgie Plastique, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Maxime Taverne
- Laboratoire Forme et Croissance du Crâne, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Antoine Fraissenon
- Institut national de la santé et de la recherche médicale U1151, Institut Necker-Enfants Malades, Paris, France
- Service d’Imagerie Pédiatrique, Hôpital Femme-Mère-Enfant, Hospices Civils de Lyon, Bron, France
- CREATIS Unité mixte de recherche 5220, Villeurbanne, France
- Service de Radiologie Mère-Enfant, Hôpital Nord, Saint Etienne, France
| | - Quentin Hennocq
- Laboratoire Forme et Croissance du Crâne, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Baptiste Periou
- Service d’anatomie Pathologique, Hôpital Henri Mondor, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Lola Zerbib
- Université Paris Cité, Paris, France
- Institut national de la santé et de la recherche médicale U1151, Institut Necker-Enfants Malades, Paris, France
- Unité de Médecine Translationnelle et Thérapies Ciblées, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Sophia Ladraa
- Université Paris Cité, Paris, France
- Institut national de la santé et de la recherche médicale U1151, Institut Necker-Enfants Malades, Paris, France
| | - Célia Chapelle
- Université Paris Cité, Paris, France
- Institut national de la santé et de la recherche médicale U1151, Institut Necker-Enfants Malades, Paris, France
| | - Clément Hoguin
- Institut national de la santé et de la recherche médicale U1151, Institut Necker-Enfants Malades, Paris, France
- Unité de Médecine Translationnelle et Thérapies Ciblées, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Sophie Kaltenbach
- Laboratoire d’Oncohématologie, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Patrick Villarese
- Laboratoire d’Oncohématologie, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Vahid Asnafi
- Université Paris Cité, Paris, France
- Institut national de la santé et de la recherche médicale U1151, Institut Necker-Enfants Malades, Paris, France
- Laboratoire d’Oncohématologie, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Christine Broissand
- Pharmacie, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Ivan Nemazanyy
- Platform for Metabolic Analyses, Structure Fédérative de Recherche Necker, Institut national de la santé et de la recherche médicale Paris, France
| | - Gwennhael Autret
- Plateforme Imageries du Vivant, Université Paris Cité, Paris Cardiovascular Research Center, Institut national de la santé et de la recherche médicale, Paris, France
| | - Nicolas Goudin
- Necker Bio-Image Analysis, Institut national de la santé et de la recherche médicale, Paris, France
| | - Christophe Legendre
- Université Paris Cité, Paris, France
- Institut national de la santé et de la recherche médicale U1151, Institut Necker-Enfants Malades, Paris, France
- Service de Néphrologie, Transplantation Adultes, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - François-Jérôme Authier
- Service d’anatomie Pathologique, Hôpital Henri Mondor, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Thomas Viel
- Plateforme Imageries du Vivant, Université Paris Cité, Paris Cardiovascular Research Center, Institut national de la santé et de la recherche médicale, Paris, France
| | - Bertrand Tavitian
- Université Paris Cité, Paris, France
- Plateforme Imageries du Vivant, Université Paris Cité, Paris Cardiovascular Research Center, Institut national de la santé et de la recherche médicale, Paris, France
| | - Cyril Gitiaux
- Université Paris Cité, Paris, France
- Service de Neurophysiologie Clinique Pédiatrique, Centre de Référence des Pathologies Neuromusculaires, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Sylvie Fraitag
- Service d’Anatomie Pathologique, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Jean-Paul Duong
- Université Paris Cité, Paris, France
- Service d’Anatomie Pathologique, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Clarisse Delcros
- Université Paris Cité, Paris, France
- Institut national de la santé et de la recherche médicale U1151, Institut Necker-Enfants Malades, Paris, France
| | - Bernard Sergent
- Service De Chirurgie Maxillo-Faciale et Chirurgie Plastique, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Arnaud Picard
- Université Paris Cité, Paris, France
- Service De Chirurgie Maxillo-Faciale et Chirurgie Plastique, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Michael Dussiot
- Institut national de la santé et de la recherche médicale U1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, Laboratoire d’Excellence GR-Ex, Paris, France
| | - Laurent Guibaud
- Institut national de la santé et de la recherche médicale U1151, Institut Necker-Enfants Malades, Paris, France
- Service d’Imagerie Pédiatrique, Hôpital Femme-Mère-Enfant, Hospices Civils de Lyon, Bron, France
| | - Roman Khonsari
- Université Paris Cité, Paris, France
- Service De Chirurgie Maxillo-Faciale et Chirurgie Plastique, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
- Laboratoire Forme et Croissance du Crâne, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Guillaume Canaud
- Université Paris Cité, Paris, France
- Institut national de la santé et de la recherche médicale U1151, Institut Necker-Enfants Malades, Paris, France
- Unité de Médecine Translationnelle et Thérapies Ciblées, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| |
Collapse
|
2
|
Ladraa S, Zerbib L, Bayard C, Fraissenon A, Venot Q, Morin G, Garneau AP, Isnard P, Chapelle C, Hoguin C, Fraitag S, Duong JP, Guibaud L, Besançon A, Kaltenbach S, Villarese P, Asnafi V, Broissand C, Goudin N, Dussiot M, Nemazanyy I, Viel T, Autret G, Cruciani-Guglielmacci C, Denom J, Bruneau J, Tavitian B, Legendre C, Dairou J, Lacorte JM, Levy P, Pende M, Polak M, Canaud G. PIK3CA gain-of-function mutation in adipose tissue induces metabolic reprogramming with Warburg-like effect and severe endocrine disruption. Sci Adv 2022; 8:eade7823. [PMID: 36490341 PMCID: PMC9733923 DOI: 10.1126/sciadv.ade7823] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/07/2022] [Accepted: 11/03/2022] [Indexed: 06/17/2023]
Abstract
PIK3CA-related overgrowth syndrome (PROS) is a genetic disorder caused by somatic mosaic gain-of-function mutations of PIK3CA. Clinical presentation of patients is diverse and associated with endocrine disruption. Adipose tissue is frequently involved, but its role in disease development and progression has not been elucidated. Here, we created a mouse model of PIK3CA-related adipose tissue overgrowth that recapitulates patient phenotype. We demonstrate that PIK3CA mutation leads to GLUT4 membrane accumulation with a negative feedback loop on insulin secretion, a burst of liver IGFBP1 synthesis with IGF-1 sequestration, and low circulating levels. Mouse phenotype was mainly driven through AKT2. We also observed that PIK3CA mutation induces metabolic reprogramming with Warburg-like effect and protein and lipid synthesis, hallmarks of cancer cells, in vitro, in vivo, and in patients. We lastly show that alpelisib is efficient at preventing and improving PIK3CA-adipose tissue overgrowth and reversing metabolomic anomalies in both animal models and patients.
Collapse
Affiliation(s)
- Sophia Ladraa
- Université Paris Cité, Paris, France
- INSERM U1151, Institut Necker-Enfants Malades, Paris, France
| | - Lola Zerbib
- Université Paris Cité, Paris, France
- INSERM U1151, Institut Necker-Enfants Malades, Paris, France
| | - Charles Bayard
- Université Paris Cité, Paris, France
- INSERM U1151, Institut Necker-Enfants Malades, Paris, France
| | - Antoine Fraissenon
- INSERM U1151, Institut Necker-Enfants Malades, Paris, France
- Service d’Imagerie Pédiatrique, Hôpital Femme-Mère-Enfant, HCL, Bron, France
- CREATIS UMR 5220, Villeurbanne 69100, France
- Service de Radiologie Mère-Enfant, Hôpital Nord, Saint Etienne, France
| | - Quitterie Venot
- Université Paris Cité, Paris, France
- INSERM U1151, Institut Necker-Enfants Malades, Paris, France
| | - Gabriel Morin
- Université Paris Cité, Paris, France
- INSERM U1151, Institut Necker-Enfants Malades, Paris, France
| | - Alexandre P. Garneau
- Université Paris Cité, Paris, France
- INSERM U1151, Institut Necker-Enfants Malades, Paris, France
| | - Pierre Isnard
- Université Paris Cité, Paris, France
- Service d’Anatomie pathologique, Hôpital Necker-Enfants Malades, AP-HP, Paris, France
| | - Célia Chapelle
- Université Paris Cité, Paris, France
- INSERM U1151, Institut Necker-Enfants Malades, Paris, France
| | - Clément Hoguin
- INSERM U1151, Institut Necker-Enfants Malades, Paris, France
- Unité de médecine translationnelle et thérapies ciblées, Hôpital Necker-Enfants Malades, AP-HP, Paris, France
| | - Sylvie Fraitag
- Service d’Anatomie pathologique, Hôpital Necker-Enfants Malades, AP-HP, Paris, France
| | - Jean-Paul Duong
- Université Paris Cité, Paris, France
- Service d’Anatomie pathologique, Hôpital Necker-Enfants Malades, AP-HP, Paris, France
| | - Laurent Guibaud
- INSERM U1151, Institut Necker-Enfants Malades, Paris, France
- Service d’Imagerie Pédiatrique, Hôpital Femme-Mère-Enfant, HCL, Bron, France
| | - Alix Besançon
- Université Paris Cité, Paris, France
- Service d’Endocrinologie, Gynécologie et Diabétologie Pédiatrique, Centre des maladies endocriniennes rares de la croissance et du développement, Hôpital Necker-Enfants Malades, AP-HP, Paris, France
| | - Sophie Kaltenbach
- Université Paris Cité, Paris, France
- Laboratoire d’Oncohématologie, Hôpital Necker-Enfants Malades, AP-HP, Paris, France
| | - Patrick Villarese
- Laboratoire d’Oncohématologie, Hôpital Necker-Enfants Malades, AP-HP, Paris, France
| | - Vahid Asnafi
- Université Paris Cité, Paris, France
- INSERM U1151, Institut Necker-Enfants Malades, Paris, France
- Laboratoire d’Oncohématologie, Hôpital Necker-Enfants Malades, AP-HP, Paris, France
| | | | - Nicolas Goudin
- Necker Bio-Image Analysis, INSERM US24/CNRS UMS 3633, Paris, France
| | - Michael Dussiot
- Université Paris Cité, Paris, France
- INSERM U1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, Laboratoire d’Excellence GR-Ex, Paris, France
| | - Ivan Nemazanyy
- Platform for Metabolic Analyses, Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS 3633, Paris, France
| | - Thomas Viel
- Plateforme Imageries du Vivant, Université de Paris, PARCC, INSERM, Paris, France
| | - Gwennhael Autret
- Plateforme Imageries du Vivant, Université de Paris, PARCC, INSERM, Paris, France
| | | | - Jessica Denom
- Université Paris Cité, Paris, France
- Unité de Biologie Fonctionnelle et Adaptative, CNRS, Paris, France
| | - Julie Bruneau
- Université Paris Cité, Paris, France
- Service d’Anatomie pathologique, Hôpital Necker-Enfants Malades, AP-HP, Paris, France
| | - Bertrand Tavitian
- Université Paris Cité, Paris, France
- Plateforme Imageries du Vivant, Université de Paris, PARCC, INSERM, Paris, France
| | - Christophe Legendre
- Université Paris Cité, Paris, France
- INSERM U1151, Institut Necker-Enfants Malades, Paris, France
- Service de Néphrologie, Transplantation Adultes, Hôpital Necker-Enfants Malades, AP-HP, Paris, France
| | - Julien Dairou
- Université Paris Cité, Paris, France
- Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, CNRS, Paris, France
| | - Jean-Marc Lacorte
- Laboratoire de Biochimie Endocrinienne et Oncologique, Hôpital La Pitié Salpêtrière, AP-HP, Paris, France
- Sorbonne Université, Paris, France
| | - Pacifique Levy
- Laboratoire de Biochimie Endocrinienne et Oncologique, Hôpital La Pitié Salpêtrière, AP-HP, Paris, France
| | - Mario Pende
- Université Paris Cité, Paris, France
- INSERM U1151, Institut Necker-Enfants Malades, Paris, France
| | - Michel Polak
- Université Paris Cité, Paris, France
- Service d’Endocrinologie, Gynécologie et Diabétologie Pédiatrique, Centre des maladies endocriniennes rares de la croissance et du développement, Hôpital Necker-Enfants Malades, AP-HP, Paris, France
| | - Guillaume Canaud
- Université Paris Cité, Paris, France
- INSERM U1151, Institut Necker-Enfants Malades, Paris, France
- Unité de médecine translationnelle et thérapies ciblées, Hôpital Necker-Enfants Malades, AP-HP, Paris, France
| |
Collapse
|
3
|
Delestre F, Venot Q, Bayard C, Fraissenon A, Ladraa S, Hoguin C, Chapelle C, Yamaguchi J, Cassaca R, Zerbib L, Magassa S, Morin G, Asnafi V, Villarese P, Kaltenbach S, Fraitag S, Duong JP, Broissand C, Boccara O, Soupre V, Bonnotte B, Chopinet C, Mirault T, Legendre C, Guibaud L, Canaud G. Alpelisib administration reduced lymphatic malformations in a mouse model and in patients. Sci Transl Med 2021; 13:eabg0809. [PMID: 34613809 DOI: 10.1126/scitranslmed.abg0809] [Citation(s) in RCA: 28] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
[Figure: see text].
Collapse
Affiliation(s)
- Florence Delestre
- Université de Paris, Paris, 75006, France.,INSERM U1151, Institut Necker-Enfants Malades, Paris, 75015, France
| | - Quitterie Venot
- Université de Paris, Paris, 75006, France.,INSERM U1151, Institut Necker-Enfants Malades, Paris, 75015, France
| | - Charles Bayard
- Université de Paris, Paris, 75006, France.,INSERM U1151, Institut Necker-Enfants Malades, Paris, 75015, France
| | - Antoine Fraissenon
- INSERM U1151, Institut Necker-Enfants Malades, Paris, 75015, France.,Service d'Imagerie Pédiatrique, Hôpital Femme-Mère-Enfant, HCL, Bron, 69500, France.,Service de Radiologie Mère-Enfant, Hôpital Nord, Saint Etienne, 42000, France
| | - Sophia Ladraa
- Université de Paris, Paris, 75006, France.,INSERM U1151, Institut Necker-Enfants Malades, Paris, 75015, France
| | - Clément Hoguin
- Université de Paris, Paris, 75006, France.,INSERM U1151, Institut Necker-Enfants Malades, Paris, 75015, France
| | - Célia Chapelle
- INSERM U1151, Institut Necker-Enfants Malades, Paris, 75015, France.,Unité d'hypercroissance dysharmonieuse et anomalies vasculaires, Hôpital Necker-Enfants Malades, AP-HP, Paris, 75015, France
| | - Junna Yamaguchi
- Université de Paris, Paris, 75006, France.,INSERM U1151, Institut Necker-Enfants Malades, Paris, 75015, France
| | - Rubina Cassaca
- Université de Paris, Paris, 75006, France.,INSERM U1151, Institut Necker-Enfants Malades, Paris, 75015, France
| | - Lola Zerbib
- Université de Paris, Paris, 75006, France.,INSERM U1151, Institut Necker-Enfants Malades, Paris, 75015, France
| | - Sato Magassa
- Université de Paris, Paris, 75006, France.,INSERM U1151, Institut Necker-Enfants Malades, Paris, 75015, France
| | - Gabriel Morin
- Université de Paris, Paris, 75006, France.,INSERM U1151, Institut Necker-Enfants Malades, Paris, 75015, France
| | - Vahid Asnafi
- Université de Paris, Paris, 75006, France.,Laboratoire d'Oncohématologie, Hôpital Necker-Enfants Malades, AP-HP, Paris, 75015, France
| | - Patrick Villarese
- Laboratoire d'Oncohématologie, Hôpital Necker-Enfants Malades, AP-HP, Paris, 75015, France
| | - Sophie Kaltenbach
- Université de Paris, Paris, 75006, France.,Laboratoire d'Oncohématologie, Hôpital Necker-Enfants Malades, AP-HP, Paris, 75015, France
| | - Sylvie Fraitag
- Département d'Anatomopathologie, Hôpital Necker-Enfants Malades, AP-HP, Paris, 75015, France
| | - Jean-Paul Duong
- Université de Paris, Paris, 75006, France.,Département d'Anatomopathologie, Hôpital Necker-Enfants Malades, AP-HP, Paris, 75015, France
| | | | - Olivia Boccara
- Service de Dermatologie, Hôpital Necker-Enfants Malades, AP-HP, Paris, 75015, France
| | - Véronique Soupre
- Service de Chirurgie Maxillo-faciale Pédiatrique, Hôpital Necker-Enfants Malades, AP-HP, 75015, Paris, France
| | - Bernard Bonnotte
- Service de Médecine Interne et Immunologie Clinique, CHU Dijon Bourgogne, Dijon, 21000, France
| | - Caroline Chopinet
- Service d'Exploration Fonctionnelle Cardiovasculaire, CHU Lille, Lille, 59000, France
| | - Tristan Mirault
- Service de Médecine Vasculaire, Hôpital Européen Georges Pompidou, AP-HP, Paris, 75015, France
| | - Christophe Legendre
- Université de Paris, Paris, 75006, France.,Service de Néphrologie et Transplantation Adultes, Hôpital Necker-Enfants Malades, AP-HP, Paris, 75015, France
| | - Laurent Guibaud
- Service d'Imagerie Pédiatrique, Hôpital Femme-Mère-Enfant, HCL, Bron, 69500, France
| | - Guillaume Canaud
- Université de Paris, Paris, 75006, France.,INSERM U1151, Institut Necker-Enfants Malades, Paris, 75015, France.,Unité d'hypercroissance dysharmonieuse et anomalies vasculaires, Hôpital Necker-Enfants Malades, AP-HP, Paris, 75015, France.,Service de Néphrologie et Transplantation Adultes, Hôpital Necker-Enfants Malades, AP-HP, Paris, 75015, France
| |
Collapse
|
4
|
Dubuisson A, Fahrner JE, Goubet AG, Terrisse S, Voisin N, Bayard C, Lofek S, Drubay D, Bredel D, Mouraud S, Susini S, Cogdill A, Rebuffet L, Ballot E, Jacquelot N, Thomas de Montpreville V, Casiraghi O, Radulescu C, Ferlicot S, Figueroa DJ, Yadavilli S, Waight JD, Ballas M, Hoos A, Condamine T, Parier B, Gaudillat C, Routy B, Ghiringhelli F, Derosa L, Breuskin I, Rouanne M, André F, Lebacle C, Baumert H, Wislez M, Fadel E, Cremer I, Albiges L, Geoerger B, Scoazec JY, Loriot Y, Kroemer G, Marabelle A, Bonvalet M, Zitvogel L. Immunodynamics of explanted human tumors for immuno-oncology. EMBO Mol Med 2020; 13:e12850. [PMID: 33372722 PMCID: PMC7799366 DOI: 10.15252/emmm.202012850] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2020] [Revised: 10/26/2020] [Accepted: 10/28/2020] [Indexed: 01/10/2023] Open
Abstract
Decision making in immuno‐oncology is pivotal to adapt therapy to the tumor microenvironment (TME) of the patient among the numerous options of monoclonal antibodies or small molecules. Predicting the best combinatorial regimen remains an unmet medical need. Here, we report a multiplex functional and dynamic immuno‐assay based on the capacity of the TME to respond to ex vivo stimulation with twelve immunomodulators including immune checkpoint inhibitors (ICI) in 43 human primary tumors. This "in sitro" (in situ/in vitro) assay has the potential to predict unresponsiveness to anti‐PD‐1 mAbs, and to detect the most appropriate and personalized combinatorial regimen. Prospective clinical trials are awaited to validate this in sitro assay.
Collapse
Affiliation(s)
- Agathe Dubuisson
- Institut Gustave Roussy, Villejuif, France.,Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France
| | - Jean-Eudes Fahrner
- Institut Gustave Roussy, Villejuif, France.,Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.,Transgene S.A, Illkirch-Graffenstaden, France
| | - Anne-Gaëlle Goubet
- Institut Gustave Roussy, Villejuif, France.,Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France
| | - Safae Terrisse
- Institut Gustave Roussy, Villejuif, France.,Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France
| | - Nicolas Voisin
- Institut Gustave Roussy, Villejuif, France.,Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France
| | - Charles Bayard
- Institut Gustave Roussy, Villejuif, France.,Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France
| | - Sebastien Lofek
- Institut Gustave Roussy, Villejuif, France.,Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France
| | - Damien Drubay
- Institut Gustave Roussy, Villejuif, France.,Service de Biostatistique et d'epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.,Oncostat U1018, Inserm, Université Paris-Saclay, Équipe Labellisée Ligue Contre le Cancer, Villejuif, France
| | - Delphine Bredel
- Institut Gustave Roussy, Villejuif, France.,Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France
| | - Séverine Mouraud
- Institut Gustave Roussy, Villejuif, France.,Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France
| | - Sandrine Susini
- Institut Gustave Roussy, Villejuif, France.,Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France
| | - Alexandria Cogdill
- Institut Gustave Roussy, Villejuif, France.,Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.,The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Lucas Rebuffet
- Institut Gustave Roussy, Villejuif, France.,Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France
| | - Elise Ballot
- Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.,Centre de Recherche INSERM LNC-UMR1231, Dijon, France
| | - Nicolas Jacquelot
- Institut Gustave Roussy, Villejuif, France.,Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.,Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia
| | | | - Odile Casiraghi
- Departement de Biologie et Pathologie Médicales, Gustave Roussy Cancer Campus, Villejuif, France
| | - Camélia Radulescu
- Service d'Anatomie et cytologie pathologiques, Hôpital Foch, Suresnes, France
| | - Sophie Ferlicot
- Service d'Anatomie et cytologie pathologiques, Hôpital Bicêtre, Le Kremlin-Bicêtre, France
| | | | | | | | - Marc Ballas
- Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA
| | - Axel Hoos
- Oncology R&D, GlaxoSmithKline, Collegeville, PA, USA
| | | | - Bastien Parier
- Service de Chirurgie urologique, Hôpital Bicêtre, Le Kremlin-Bicêtre, France
| | | | - Bertrand Routy
- Division of Oncology, Department of Medicine, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.,Hematology-Oncology Division, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC, Canada
| | - François Ghiringhelli
- Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.,Centre de Recherche INSERM LNC-UMR1231, Dijon, France.,Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France
| | - Lisa Derosa
- Institut Gustave Roussy, Villejuif, France.,Departement de Médicine Oncologique, Gustave Roussy Cancer Campus, Villejuif, France
| | - Ingrid Breuskin
- Département de Chirurgie, Gustave Roussy, Université Paris-Saclay, Villejuif, France
| | - Mathieu Rouanne
- Institut Gustave Roussy, Villejuif, France.,Departement de Biologie et Pathologie Médicales, Gustave Roussy Cancer Campus, Villejuif, France.,Service d'Urologie, Hôpital Foch, Suresnes, France.,UVSQ - Université Paris Saclay, Versailles, France
| | - Fabrice André
- Institut Gustave Roussy, Villejuif, France.,Gustave Roussy, Université Paris-Saclay, Villejuif, France
| | - Cédric Lebacle
- Service de Chirurgie urologique, Hôpital Bicêtre, Le Kremlin-Bicêtre, France
| | | | - Marie Wislez
- AP-HP, Centre - Université de Paris, Hôpital Cochin, Unité d'Oncologie Thoracique, Service de Pneumologie, Paris, France.,AP-HP, Hôpitaux Universitaires de l'Est Parisien, Hôpital Tenon, Service de Pneumologie, Paris, France
| | - Elie Fadel
- Service de Chirurgie Thoracique, Hôpital Marie Lannelongue, Le Plessis-Robinson, France
| | - Isabelle Cremer
- Team Inflammation, Complement and Cancer, INSERM, Centre de Recherche des Cordeliers, Paris, France.,Sorbonne Université, Paris, France
| | - Laurence Albiges
- Institut Gustave Roussy, Villejuif, France.,Departement de Médicine Oncologique, Gustave Roussy Cancer Campus, Villejuif, France
| | - Birgit Geoerger
- Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France
| | - Jean-Yves Scoazec
- Institut Gustave Roussy, Villejuif, France.,Departement de Biologie et Pathologie Médicales, Gustave Roussy Cancer Campus, Villejuif, France
| | - Yohann Loriot
- Institut Gustave Roussy, Villejuif, France.,Departement de Médicine Oncologique, Gustave Roussy Cancer Campus, Villejuif, France
| | - Guido Kroemer
- Institut Gustave Roussy, Villejuif, France.,Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM U1138, Institut Universitaire de France, Paris, France.,Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France.,Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.,Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, China.,Department of Women's and Children's Health, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
| | - Aurélien Marabelle
- Institut Gustave Roussy, Villejuif, France.,Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy, Université Paris-Saclay, Villejuif, France
| | - Mélodie Bonvalet
- Institut Gustave Roussy, Villejuif, France.,Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France
| | - Laurence Zitvogel
- Institut Gustave Roussy, Villejuif, France.,Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.,Gustave Roussy, Université Paris-Saclay, Villejuif, France.,Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France
| |
Collapse
|
5
|
Vallet H, Bayard C, Lepetitcorps H, O'Hana J, Fastenackels S, Fali T, Cohen-Bittan J, Khiami F, Boddaert J, Sauce D. Hip Fracture Leads to Transitory Immune Imprint in Older Patients. Front Immunol 2020; 11:571759. [PMID: 33072114 PMCID: PMC7533556 DOI: 10.3389/fimmu.2020.571759] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2020] [Accepted: 08/13/2020] [Indexed: 11/13/2022] Open
Abstract
Background: Hip fracture (HF) is common in the geriatric population and is associated with a poor vital and functional prognosis which could be impacted by immunological changes. The objective here is to decipher immune changes occurring in the 1st days following HF and determine how phenotype, function, and regulation of innate and adaptive compartments adapt during acute stress event. Methods: We included HF patients, aged over 75 years. For each patient, blood samples were taken at five different timepoints: four in the perioperative period (day 0 to hospital discharge) and one at long term (6–12 months). Phenotypical and functional analysis were performed longitudinally on fresh blood or cryopreserved PBMCs. Clinical data were prospectively collected. Results: One-hundred HF patients and 60 age-matched controls were included. Innate compartment exhibits pro-inflammatory phenotypes (hyperleukocytosis, increase of CD14+ CD16+ proportion and CCR2 expression), maintaining its ability to produce pro-inflammatory cytokines. Adaptive compartment extends toward a transitory immunosuppressive profile (leucopenia) associated with an active T-cell proliferation. Furthermore, increases of LAG-3 and PD-1 and a decrease of 2-B4 expression are observed on T-cells, reinforcing their transitory suppressive status. Of note, these immune changes are transitory and sequential but may participate to a regulation loop necessary for homeostatic immune control at long term. Conclusion: HF is associated with several transitory immunological changes including pro-inflammatory phenotype in innate compartment and immunosuppressive profile in adaptive compartment. A comprehensive assessment of immune mechanisms implicated in the patient's prognosis after HF could pave the way to develop new immune therapeutics strategies.
Collapse
Affiliation(s)
- Héléne Vallet
- Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), Paris, France.,Assistance Publique Hôpitaux de Paris (APHP), Hôpital Saint Antoine, Department of Geriatrics, Paris, France
| | - Charles Bayard
- Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), Paris, France
| | - Héléne Lepetitcorps
- Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), Paris, France
| | - Jessica O'Hana
- Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), Paris, France
| | - Soléne Fastenackels
- Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), Paris, France
| | - Tinhinane Fali
- Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), Paris, France
| | - Judith Cohen-Bittan
- Assistance Publique Hôpitaux de Paris (APHP), Hôpital Pitié-Salpétrière, Department of Geriatrics, Paris, France
| | - Frédéric Khiami
- Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), Paris, France.,APHP, Hôpital Pitié-Salpétrière, Department of Orthopedic Surgery, Paris, France
| | - Jacques Boddaert
- Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), Paris, France.,Assistance Publique Hôpitaux de Paris (APHP), Hôpital Pitié-Salpétrière, Department of Geriatrics, Paris, France
| | - Delphine Sauce
- Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), Paris, France
| |
Collapse
|
6
|
Fali T, Papagno L, Bayard C, Mouloud Y, Boddaert J, Sauce D, Appay V. New Insights into Lymphocyte Differentiation and Aging from Telomere Length and Telomerase Activity Measurements. J I 2019; 202:1962-1969. [DOI: 10.4049/jimmunol.1801475] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/02/2018] [Accepted: 01/14/2019] [Indexed: 01/13/2023]
|
7
|
Weber L, Poletti V, Magrin E, Antoniani C, Martin S, Bayard C, Sadek H, Felix T, Meneghini V, Antoniou MN, El-Nemer W, Mavilio F, Cavazzana M, Andre-Schmutz I, Miccio A. An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype. Mol Ther Methods Clin Dev 2018; 10:268-280. [PMID: 30140714 PMCID: PMC6105766 DOI: 10.1016/j.omtm.2018.07.012] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/26/2018] [Accepted: 07/29/2018] [Indexed: 12/17/2022]
Abstract
Autologous transplantation of hematopoietic stem cells transduced with a lentiviral vector (LV) expressing an anti-sickling HBB variant is a potential treatment for sickle cell disease (SCD). With a clinical trial as our ultimate goal, we generated LV constructs containing an anti-sickling HBB transgene (HBBAS3), a minimal HBB promoter, and different combinations of DNase I hypersensitive sites (HSs) from the locus control region (LCR). Hematopoietic stem progenitor cells (HSPCs) from SCD patients were transduced with LVs containing either HS2 and HS3 (β-AS3) or HS2, HS3, and HS4 (β-AS3 HS4). The inclusion of the HS4 element drastically reduced vector titer and infectivity in HSPCs, with negligible improvement of transgene expression. Conversely, the LV containing only HS2 and HS3 was able to efficiently transduce SCD bone marrow and Plerixafor-mobilized HSPCs, with anti-sickling HBB representing up to ∼60% of the total HBB-like chains. The expression of the anti-sickling HBB and the reduced incorporation of the βS-chain in hemoglobin tetramers allowed up to 50% reduction in the frequency of RBC sickling under hypoxic conditions. Together, these results demonstrate the ability of a high-titer LV to express elevated levels of a potent anti-sickling HBB transgene ameliorating the SCD cell phenotype.
Collapse
Affiliation(s)
- Leslie Weber
- Laboratory of Human Lymphohematopoiesis, INSERM UMR_S1163, 75015 Paris, France.,Paris Diderot University - Sorbonne Paris Cité, 75015 Paris, France
| | | | - Elisa Magrin
- Biotherapy Department, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, 75015 Paris, France
| | - Chiara Antoniani
- Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, 75015 Paris, France.,Laboratory of chromatin and gene regulation during development, INSERM UMR_S1163, 75015 Paris, France
| | | | - Charles Bayard
- Laboratory of Human Lymphohematopoiesis, INSERM UMR_S1163, 75015 Paris, France
| | - Hanem Sadek
- Laboratory of Human Lymphohematopoiesis, INSERM UMR_S1163, 75015 Paris, France
| | - Tristan Felix
- Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, 75015 Paris, France.,Laboratory of chromatin and gene regulation during development, INSERM UMR_S1163, 75015 Paris, France
| | - Vasco Meneghini
- Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, 75015 Paris, France.,Laboratory of chromatin and gene regulation during development, INSERM UMR_S1163, 75015 Paris, France
| | | | - Wassim El-Nemer
- Biologie Intégrée du Globule Rouge, INSERM UMR_S1134, Paris Diderot University, Sorbonne Paris Cité, Université de la Réunion, Université des Antilles, 75015 Paris, France.,Institut National de la Transfusion Sanguine, 75015 Paris, France.,Laboratoire d'Excellence GR-Ex, 75015 Paris, France
| | - Fulvio Mavilio
- Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, 75015 Paris, France.,Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy
| | - Marina Cavazzana
- Laboratory of Human Lymphohematopoiesis, INSERM UMR_S1163, 75015 Paris, France.,Biotherapy Department, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, 75015 Paris, France.,Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, 75015 Paris, France
| | - Isabelle Andre-Schmutz
- Laboratory of Human Lymphohematopoiesis, INSERM UMR_S1163, 75015 Paris, France.,Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, 75015 Paris, France
| | - Annarita Miccio
- Genethon, INSERM UMR951, 91000 Evry, France.,Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, 75015 Paris, France.,Laboratory of chromatin and gene regulation during development, INSERM UMR_S1163, 75015 Paris, France
| |
Collapse
|
8
|
Fali T, Fabre-Mersseman V, Yamamoto T, Bayard C, Papagno L, Fastenackels S, Zoorab R, Koup RA, Boddaert J, Sauce D, Appay V. Elderly human hematopoietic progenitor cells express cellular senescence markers and are more susceptible to pyroptosis. JCI Insight 2018; 3:95319. [PMID: 29997288 DOI: 10.1172/jci.insight.95319] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2017] [Accepted: 05/31/2018] [Indexed: 01/24/2023] Open
Abstract
The maintenance of effective immunity over time is dependent on the capacity of hematopoietic stem cells (HSCs) to sustain the pool of immunocompetent mature cells. Decline of immune competence with old age may stem from HSC defects, including reduced self-renewal potential and impaired lymphopoiesis, as suggested in murine models. To obtain further insights into aging-related alteration of hematopoiesis, we performed a comprehensive study of blood hematopoietic progenitor cells (HPCs) from older humans. In the elderly, HPCs present active oxidative phosphorylation and are pressed to enter cell cycling. However, p53-p21 and p15 cell senescence pathways, associated with telomerase activity deficiency, strong telomere attrition, and oxidative stress, are engaged, thus limiting cell cycling. Moreover, survival of old HPCs is impacted by pyroptosis, an inflammatory form of programmed cell death. Lastly, telomerase activity deficiency and telomere length attrition of old HPCs may be passed on to progeny cells such as naive T lymphocytes, further highlighting the poor hematopoietic potential of the elderly. This pre-senescent profile is characteristic of the multiple intrinsic and extrinsic factors affecting HPCs in elderly individuals and represents a major obstacle in terms of immune reconstitution and efficacy with advanced age.
Collapse
Affiliation(s)
- Tinhinane Fali
- Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France
| | - Véronique Fabre-Mersseman
- Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France
| | - Takuya Yamamoto
- Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.,Laboratory of Immunosenescence, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki-City, Osaka, Japan.,Center for AIDS Research, Kumamoto University, Kumamoto, Japan
| | - Charles Bayard
- Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France
| | - Laura Papagno
- Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France
| | - Solène Fastenackels
- Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France
| | - Rima Zoorab
- Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France
| | - Richard A Koup
- Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA
| | - Jacques Boddaert
- AP-HP, Hôpital Pitié-Salpêtrière, Service de Gériatrie, Paris, France
| | - Delphine Sauce
- Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France
| | - Victor Appay
- Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.,International Research Center of Medical Sciences (IRCMS), Kumamoto University, Kumamoto, Japan
| |
Collapse
|
9
|
Larsen M, Bayard C, Lepetitcorps H, Cohen-Bittan J, Appay V, Boddaert J, Sauce D. Elevated Neopterin Levels Predict Early Death in Older Hip-fracture Patients. EBioMedicine 2017; 26:157-164. [PMID: 29157836 PMCID: PMC5832560 DOI: 10.1016/j.ebiom.2017.11.003] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2017] [Revised: 11/03/2017] [Accepted: 11/03/2017] [Indexed: 12/11/2022] Open
Abstract
Our society faces a major challenge concerning management of the health and socio-economic burden caused by acute physical stress in the older population (+ 75 years). In particular, hip-fracture surgery (HFS) represents a major health care preoccupation, affecting 1.6 million patients worldwide, resulting in a significant drop in life quality and autonomy. The trauma is associated with 20–30% one-year mortality in the elderly. In the present study, we aim to identify factors, which influence and/or predict the outcome of elderly hip- fracture patients (HFP) post-surgery. Our objective was to identify biomarkers with a prognostic capacity of one-year mortality. We employed an observational cohort of HFP (n = 60) followed-up longitudinally during the first year post fracture. Clinical and biological data (n = 136), collected at arrival to hospital, were then compared to healthy controls (n = 42) and analyzed using a regularized logistic regression model with lasso penalty followed by 10-fold cross-validation of variables. We show that plasmatic neopterin levels, a molecule released by IFN-γ-activated macrophages, is predictive of mortality in HFP (ROC-AUC = 0.859). Moreover, neopterin measured at arrival to the hospital correlated negatively with the time of survival after HFS. Neopterin therefore represents a biomarker, which enables better follow-up of patients at risk of early death. Neopterin level, measured at arrival to hospital, is a robust predictive marker of one-year mortality in HFPs. Neopterin concentration correlated negatively with the time of survival after hip fracture surgery.
The growing incidence of hip fractures, due to demographically aging populations, represent an important burden for health care systems and for injured patients in terms of hospitalization, rehabilitation, needs for long-term care, change in autonomy and mortality. Hip fractures are associated with high rates of adverse outcome, but previous studies have not discovered methods to identify patients at high risk of pernicious clinical outcome or death. Here, we show that innate immune activation post hip fracture in older adults is associated with pernicious clinical outcome.
Collapse
Affiliation(s)
- Martin Larsen
- INSERM, U1135, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), F-75013 Paris, France
| | - Charles Bayard
- INSERM, U1135, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), F-75013 Paris, France
| | - Hélène Lepetitcorps
- INSERM, U1135, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), F-75013 Paris, France
| | - Judith Cohen-Bittan
- AP-HP, Service de gériatrie, Hôpital Pitié-Salpêtrière, F-75013 Paris, France
| | - Victor Appay
- INSERM, U1135, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), F-75013 Paris, France; Sorbonne Universités, UPMC Univ Paris 06, DHU FAST, CR7, F-75013 Paris, France
| | - Jacques Boddaert
- AP-HP, Service de gériatrie, Hôpital Pitié-Salpêtrière, F-75013 Paris, France; Sorbonne Universités, UPMC Univ Paris 06, DHU FAST, CR7, F-75013 Paris, France
| | - Delphine Sauce
- INSERM, U1135, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), F-75013 Paris, France; Sorbonne Universités, UPMC Univ Paris 06, DHU FAST, CR7, F-75013 Paris, France.
| |
Collapse
|
10
|
Sauce D, Le Petitcorps H, Larsen M, Bayard C, Appay V, Boddaert J. ACUTE MACROPHAGE ACTIVATION PREDICTS SURVIVAL POST-HIP FRACTURE SURGERY IN ELDERLY. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.3532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- D. Sauce
- INSERM U1135, Cimi-Paris, UPMC, INSERM U1135, Cimi-Paris, UPMC, Paris, France,
- Sorbonne Université, UPMC Paris VI, DHU Fast, Paris, France,
| | - H. Le Petitcorps
- INSERM U1135, Cimi-Paris, UPMC, INSERM U1135, Cimi-Paris, UPMC, Paris, France,
| | - M. Larsen
- INSERM U1135, Cimi-Paris, UPMC, INSERM U1135, Cimi-Paris, UPMC, Paris, France,
| | - C. Bayard
- INSERM U1135, Cimi-Paris, UPMC, INSERM U1135, Cimi-Paris, UPMC, Paris, France,
| | - V. Appay
- INSERM U1135, Cimi-Paris, UPMC, INSERM U1135, Cimi-Paris, UPMC, Paris, France,
- Sorbonne Université, UPMC Paris VI, DHU Fast, Paris, France,
| | - J. Boddaert
- Pitié Salpétrière Hospital, Geriatric Department, Paris, France
- Sorbonne Université, UPMC Paris VI, DHU Fast, Paris, France,
| |
Collapse
|
11
|
Angin M, Wong G, Papagno L, Versmisse P, David A, Bayard C, Charmeteau-De Muylder B, Besseghir A, Thiébaut R, Boufassa F, Pancino G, Sauce D, Lambotte O, Brun-Vézinet F, Matheron S, Rowland-Jones SL, Cheynier R, Sáez-Cirión A, Appay V. Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected Controllers. J Immunol 2016; 197:2787-95. [PMID: 27566819 DOI: 10.4049/jimmunol.1600693] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/19/2016] [Accepted: 07/23/2016] [Indexed: 12/14/2022]
Abstract
Compared with HIV-1, HIV-2 infection is characterized by a larger proportion of slow or nonprogressors. A better understanding of HIV-2 pathogenesis should open new therapeutic avenues to establish control of HIV-1 replication in infected patients. In this study, we studied the production of CD8(+) T cells and their capacity for viral control in HIV-2 controllers from the French ANRS CO5 HIV-2 cohort. HIV-2 controllers display a robust capacity to support long-term renewal of the CD8(+) T cell compartment by preserving immune resources, including hematopoietic progenitors and thymic activity, which could contribute to the long-term maintenance of the CD8(+) T cell response and the avoidance of premature immune aging. Our data support the presence of HIV-2 Gag-specific CD8(+) T cells that display an early memory differentiation phenotype and robust effector potential in HIV-2 controllers. Accordingly, to our knowledge, we show for the first time that HIV-2 controllers possess CD8(+) T cells that show an unusually strong capacity to suppress HIV-2 infection in autologous CD4(+) T cells ex vivo, an ability that likely depends on the preservation of host immune resources. This effective and durable antiviral response probably participates in a virtuous circle, during which controlled viral replication permits the preservation of potent immune functions, thus preventing HIV-2 disease progression.
Collapse
Affiliation(s)
- Mathieu Angin
- Institut Pasteur, Unité HIV Inflammation et Persistance, Paris 75015, France
| | - Glenn Wong
- Sorbonne Universités, Université Pierre et Marie Curie, Université Paris 06, DHU FAST, CR7, Centre d'Immunologie et des Maladies Infectieuses, INSERM U1135, Paris 75005, France; Nuffield Department of Medicine, Headington, Oxford OX3 7FZ, United Kingdom
| | - Laura Papagno
- Sorbonne Universités, Université Pierre et Marie Curie, Université Paris 06, DHU FAST, CR7, Centre d'Immunologie et des Maladies Infectieuses, INSERM U1135, Paris 75005, France
| | - Pierre Versmisse
- Institut Pasteur, Unité HIV Inflammation et Persistance, Paris 75015, France
| | - Annie David
- Institut Pasteur, Unité HIV Inflammation et Persistance, Paris 75015, France
| | - Charles Bayard
- Sorbonne Universités, Université Pierre et Marie Curie, Université Paris 06, DHU FAST, CR7, Centre d'Immunologie et des Maladies Infectieuses, INSERM U1135, Paris 75005, France
| | - Bénédicte Charmeteau-De Muylder
- INSERM U1016, Institut Cochin, Cytokines and Viral Infections Team, Paris 75014, France; CNRS UMR 8104, Université Paris Descartes, Sorbonne Paris Cité, Paris 75014, France
| | - Amel Besseghir
- Centre de Méthodologie et de Gestion des Essais Cliniques de l'INSERM U1219, Virus de l'Immunodéficience Humaine, Hépatites Virales et Comorbidités, Épidémiologie Clinique et Santé Publique, Bordeaux 33076, France
| | - Rodolphe Thiébaut
- Centre de Méthodologie et de Gestion des Essais Cliniques de l'INSERM U1219, Virus de l'Immunodéficience Humaine, Hépatites Virales et Comorbidités, Épidémiologie Clinique et Santé Publique, Bordeaux 33076, France
| | - Faroudy Boufassa
- INSERM U1018, Centre de Recherche en Epidémiologie et Santé des Populations, Université Paris Sud, Le Kremlin Bicêtre 94270, France
| | - Gianfranco Pancino
- Institut Pasteur, Unité HIV Inflammation et Persistance, Paris 75015, France
| | - Delphine Sauce
- Sorbonne Universités, Université Pierre et Marie Curie, Université Paris 06, DHU FAST, CR7, Centre d'Immunologie et des Maladies Infectieuses, INSERM U1135, Paris 75005, France
| | - Olivier Lambotte
- INSERM UMR 1184, Immunologie des Maladies Virales et Autoimmunes, Le Kremlin Bicêtre 94270, France; Assistance Publique-Hôpitaux de Paris, Service de Médecine Interne, Hôpitaux Universitaires, Le Kremlin Bicêtre 94270, France; Université Paris Sud, Le Kremlin Bicêtre 94270, France
| | - Françoise Brun-Vézinet
- Assistance Publique-Hôpitaux de Paris, Laboratoire de Virologie, Hôpital Bichat, Paris 75018, France
| | - Sophie Matheron
- INSERM UMR 1137, Infections, Antimicrobiens, Modélisation, Evolution, Université Paris Diderot, Sorbonne Paris Cité, Paris 75018, France; and Assistance Publique-Hôpitaux de Paris, Service des Maladies Infectieuses et Tropicales, Hôpital Bichat, Paris 75018, France
| | | | - Rémi Cheynier
- INSERM U1016, Institut Cochin, Cytokines and Viral Infections Team, Paris 75014, France; CNRS UMR 8104, Université Paris Descartes, Sorbonne Paris Cité, Paris 75014, France
| | - Asier Sáez-Cirión
- Institut Pasteur, Unité HIV Inflammation et Persistance, Paris 75015, France;
| | - Victor Appay
- Sorbonne Universités, Université Pierre et Marie Curie, Université Paris 06, DHU FAST, CR7, Centre d'Immunologie et des Maladies Infectieuses, INSERM U1135, Paris 75005, France;
| | | |
Collapse
|
12
|
Sauce D, Dong Y, Campillo-Gimenez L, Casulli S, Bayard C, Autran B, Boddaert J, Appay V, Elbim C. Reduced Oxidative Burst by Primed Neutrophils in the Elderly Individuals Is Associated With Increased Levels of the CD16bright/CD62LdimImmunosuppressive Subset. J Gerontol A Biol Sci Med Sci 2016; 72:163-172. [DOI: 10.1093/gerona/glw062] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2015] [Accepted: 03/16/2016] [Indexed: 12/28/2022] Open
|
13
|
Bayard C, Lepetitcorps H, Roux A, Larsen M, Fastenackels S, Salle V, Vieillard V, Marchant A, Stern M, Boddaert J, Bajolle F, Appay V, Sauce D. Coordinated expansion of both memory T cells and NK cells in response to CMV infection in humans. Eur J Immunol 2016; 46:1168-79. [DOI: 10.1002/eji.201546179] [Citation(s) in RCA: 38] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2015] [Revised: 12/28/2015] [Accepted: 02/17/2016] [Indexed: 12/18/2022]
Affiliation(s)
- Charles Bayard
- Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris); Sorbonne Universités; DHU FAST, CR7, UPMC Univ Paris 06 Paris France
- INSERM, U1135; CIMI-Paris; Paris France
| | - Hélène Lepetitcorps
- Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris); Sorbonne Universités; DHU FAST, CR7, UPMC Univ Paris 06 Paris France
- INSERM, U1135; CIMI-Paris; Paris France
| | - Antoine Roux
- Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris); Sorbonne Universités; DHU FAST, CR7, UPMC Univ Paris 06 Paris France
- INSERM, U1135; CIMI-Paris; Paris France
- AP-HP, Service de pneumologie; Hôpital Foch; Suresnes France
| | - Martin Larsen
- Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris); Sorbonne Universités; DHU FAST, CR7, UPMC Univ Paris 06 Paris France
- INSERM, U1135; CIMI-Paris; Paris France
| | - Solène Fastenackels
- Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris); Sorbonne Universités; DHU FAST, CR7, UPMC Univ Paris 06 Paris France
- INSERM, U1135; CIMI-Paris; Paris France
| | - Virginie Salle
- AP-HP; Unité Médico-Chirurgicale de Cardiologie Congénitale et Pédiatrique/ M3C; Hôpital Necker enfants malades; Paris France
| | - Vincent Vieillard
- Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris); Sorbonne Universités; DHU FAST, CR7, UPMC Univ Paris 06 Paris France
- INSERM, U1135; CIMI-Paris; Paris France
| | - Arnaud Marchant
- Institute for Medical Immunology; Université Libre de Bruxelles; Charleroi Belgium
| | - Marc Stern
- AP-HP, Service de pneumologie; Hôpital Foch; Suresnes France
| | - Jacques Boddaert
- AP-HP; Service de gériatrie; Hôpital Pitié-Salpêtrière; Paris France
| | - Fanny Bajolle
- AP-HP; Unité Médico-Chirurgicale de Cardiologie Congénitale et Pédiatrique/ M3C; Hôpital Necker enfants malades; Paris France
| | - Victor Appay
- Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris); Sorbonne Universités; DHU FAST, CR7, UPMC Univ Paris 06 Paris France
- INSERM, U1135; CIMI-Paris; Paris France
| | - Delphine Sauce
- Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris); Sorbonne Universités; DHU FAST, CR7, UPMC Univ Paris 06 Paris France
- INSERM, U1135; CIMI-Paris; Paris France
| |
Collapse
|
14
|
Colin C, Zuinen T, Bayard C, Leybaert J. Phonological processing of rhyme in spoken language and location in sign language by deaf and hearing participants: A neurophysiological study. Neurophysiol Clin 2013; 43:151-60. [DOI: 10.1016/j.neucli.2013.03.001] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2012] [Revised: 11/30/2012] [Accepted: 03/21/2013] [Indexed: 11/28/2022] Open
|
15
|
Burban A, Faucard R, Armand V, Bayard C, Vorobjev V, Arrang JM. Histamine Potentiates N-Methyl-d-aspartate Receptors by Interacting with an Allosteric Site Distinct from the Polyamine Binding Site. J Pharmacol Exp Ther 2009; 332:912-21. [DOI: 10.1124/jpet.109.158543] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
16
|
|
17
|
Jabri AL, Bayard C. Nesidioblastosis associated with hyperinsulinemic hypoglycemia in adults: review of the literature. Eur J Intern Med 2004; 15:407-410. [PMID: 15581742 DOI: 10.1016/j.ejim.2004.06.012] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/30/2003] [Revised: 06/03/2004] [Accepted: 06/17/2004] [Indexed: 12/18/2022]
Abstract
Nesidioblastosis is a term that was first introduced by Laidlaw in 1938 to define the diffuse proliferation of pancreatic islet cells budding from ductal epithelium. First described in neonates, it is widely recognized to be the primary cause of persistent hyperinsulinemic hypoglycemia in infants. In adults, insulinoma accounts for most cases of hyperinsulinemic hypoglycemia. Adult-onset nesidioblastosis associated with hyperinsulinemic hypoglycemia is a very rare entity, representing 0.5-5% of cases of organic hyperinsulinemia. Since 1981, when Harness et al. reported the first series of adult nesidioblastosis causing hypoglycemia, only 71 cases have been published. This article provides a guide for the diagnosis of organic hyperinsulinism and indicates when nesidioblastosis should be suspected. New diagnostic methods and treatment options for this rare disease are proposed. We also present a review of all reported cases of adult nesidioblastosis in the last 22 years.
Collapse
Affiliation(s)
- A L Jabri
- Sion Regional Hospital, Geriatrics Department (Gravelone), 1951 Sion. A. L. Jabri, Les Sorbiers 10, 1530 Payerne, Switzerland
| | | |
Collapse
|
18
|
Feille F, Bayard C, Bonal M, Gimenez C, Giraud F, Lefebvre V, Nogues M, Piens-Bordenave S, Philippe J, Pinaud J, Roncier M, Ruggiu M, Tello V. Mise en place de la pluridisciplinarité dans un service de santé au travail. ARCH MAL PROF ENVIRO 2004. [DOI: 10.1016/s1775-8785(04)93362-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
19
|
Abstract
Allergens from the view of a protein chemist are quite normal proteins, not to distinguish from non allergenic proteins. The first task is therefore to recognize and identify the proteins responsible for the allergenic reaction. This is usually only possible if the allergenic structure is conserved during the purification procedures. For a detailed analysis of the allergenic protein modern protein chemical methods for characterization, identification, determination of posttranslational modifications and epitope characterization have to be applied. Such techniques are briefly described in this article.
Collapse
Affiliation(s)
- C Bayard
- Max-Planck-Institute for Biochemistry, Martinsried, Germany.
| | | |
Collapse
|
20
|
Bayard C, Siddique AB, Berzins K, Troye-Blomberg M, Hellman U, Vesterberg O. Mapping of IgE binding regions in the major rat urinary protein, alpha 2u-globulin, using overlapping peptides. Immunol Invest 1999; 28:323-38. [PMID: 10574630 DOI: 10.3109/08820139909062266] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Exposure to laboratory animals poses a hazard for development of occupational allergy. Identification of antigenic determinants of allergenic proteins may be valuable for immunotherapeutic purposes. Overlapping peptides of the major allergen in rat urine, Rat n 1.02, corresponding to the protein alpha2u-globulin were synthesised on solid support and screened simultaneously to locate IgE binding linear epitopes using a simple modified ELISA procedure. Thirty-nine peptides were synthesised, each 8 amino acids long with 4 amino acids overlaps. Sera from fifteen rat-sensitized subjects were analyzed and as controls sera from 7 non-rat-sensitized individuals were used. In general low binding and a great individual variation between sera from rat allergic individuals were seen. Some peptides were more frequently recognized by IgE antibodies in sera from rat allergics. These peptides were mainly clustered towards the N-terminal and C-terminal parts of the protein. Taken together our data suggest the existence of linear IgE binding epitopes in the rat urine allergen, Rat n 1.02. However, the role of these sequences in the allergic reaction needs further investigation.
Collapse
Affiliation(s)
- C Bayard
- Department of Occupational Medicine, National Institute for Working Life, Solna, Sweden.
| | | | | | | | | | | |
Collapse
|
21
|
Abstract
Work with laboratory animals involves the increased risk of developing an allergy. Certain proteins in male rat urine have been shown to be major allergens, i.e., Rat n 1.01 and Rat n 1.02. Rat urinary proteins separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were electro-blotted to polyvinylidene difluoride (PVDF) membranes. Immunoblot analysis of human IgE binding components in rat urine utilizing chemiluminescence and a newly developed luminometer is described. Luminometer scanning curves of IgE reactivity to the separated rat urinary proteins are demonstrated. Rat allergic individuals showed different immune responses to the separated proteins. Rat n 1.02, also known as the major protein alpha2mu-globulin, was not always the dominant allergen. Another protein in the albumin region, 60-67 kDa, was found to be an important allergen to some rat-sensitive subjects. Reactivity in the skin prick test with purified Rat n 1.01 and Rat n 1.02 fractions were strong. However, in dot blot under nondenaturing conditions, only weak responses were obtained to the purified rat urinary proteins except for the albumin fraction. Chemiluminescence measurements in blotting membranes of patient IgE bound to different dilutions of certain rat urine proteins revealed good quantitative relationships. Three different chemiluminescence substrates were tested. Measurement of IgE bound to individual allergens as well as the abundance and relative importance of various allergens were studied.
Collapse
Affiliation(s)
- C Bayard
- Department of Occupational Medicine, National Institute for Working Life, Solna, Sweden.
| | | |
Collapse
|
22
|
Abstract
A new technique is presented to detect and quantify birch (Betula pendula)-pollen allergens directly on air-sampling filters. It is based on the use of specific antibodies, enzymatic reactions, and measurement by chemiluminescence or densitometry. The major pollen antigens are the most important birch allergens. The antibodies used recognize birch-pollen antigens which thus correspond to allergens. Calibration was done with a standardized extract of birch pollen for skin prick testing. The correlation coefficient for the logarithms of luminescence and the amount of birch-pollen allergen applied on filters was > 0.98 in the range 0.04-200 SQ units. A similar correlation was found for the logarithms of the integrated densitometry values and the amount of birch-pollen allergen applied on filters. The number of major pollen-antigen particles or grains on filters could be estimated by counting the major stained spots produced by precipitated enzymatic products. The correlation coefficient was 0.90 for the logarithms of the number of counted major antigen spots and the calculated antigen amount obtained by luminometric measurements. Our results demonstrate that birch-pollen allergens can be determined directly on air-sampling, Teflon-based filters by luminometry, optical density, or particle counting.
Collapse
Affiliation(s)
- F Acevedo
- Department of Occupational Medicine, National Institute for Working Life, Solna, Sweden
| | | | | |
Collapse
|
23
|
Renström A, Larsson PH, Malmberg P, Bayard C. A new amplified monoclonal rat allergen assay used for evaluation of ventilation improvements in animal rooms. J Allergy Clin Immunol 1997; 100:649-55. [PMID: 9389295 DOI: 10.1016/s0091-6749(97)70169-6] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
BACKGROUND Available methods for the measurement of airborne laboratory animal allergens are not standardized and are often insufficiently sensitive for measurements in laboratories or in undisturbed animal rooms. Although low, the levels may be clinically relevant, because many scientists not involved in cleaning out cages or handling animals have rodent allergies. OBJECTIVE The purpose of this study was to develop a sensitive monoclonal assay to determine airborne rat allergen and test it in the evaluation of a sliding curtain system installed in refurbished rat rooms, with perforated, transparent polycarbonate screens, behind which were the cage racks. METHODS Monoclonal antibodies were produced against male rat urine by immunization in mice and fusion with mouse cell line Sp2/0. A novel biotinylated phenol compound was synthesized for immunoassay signal amplification in conjunction with horseradish peroxidase. Air filter samples were collected at a rate of 2 L/min, and allergen content in the filter eluates was determined. RESULTS Two monoclonal antibodies were produced and used in a sandwich ELISA, which bound alpha2u-globulin (Rat n 1.02). The assay detection limit was 3.2 pg/ml, about tenfold increased sensitivity compared with the unamplified assay. Allergen levels were lower in rooms when curtains were closed (median, 0.2 ng/m3) than behind the curtains (0.9 ng/m3, p = 0.01) or if the curtains were open (0.9 ng/m3, p = 0.001). However, allergen levels during cage cleaning, when curtains were drawn apart, were high (18 ng/m3). CONCLUSION We have developed a method for measurement of airborne rat allergen that can be standardized, measures an important allergen, and is sufficiently sensitive to measure low allergen levels with personal samplers.
Collapse
Affiliation(s)
- A Renström
- Department of Occupational Health, National Institute for Working Life, Solna, Sweden
| | | | | | | |
Collapse
|
24
|
Bayard C, Venetz AM. [A palliative care center and approach to death in Valais: l'Antenne François-Xavier Bagnoud]. Rev Med Suisse Romande 1997; 117:255-260. [PMID: 9198878] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Affiliation(s)
- C Bayard
- Antenne François-Xavier Bagnoud, Sion
| | | |
Collapse
|
25
|
Abstract
Amino-acid compositional and sequence analyses as well as mass spectrometric determinations of purified rat urine proteins, previously termed prealbumin and alpha(2)-euglobulin, have revealed a high homology between the two forms which have now been identified as alpha(2)-globulin species. The "prealbumin' fraction was found to correspond to alpha(2u)-globulin originating from salivary gland and the 'alpha(2)-euglobulin' fraction was identical with the major urinary protein (MUP) or alpha(2u)-globulin. The results indicate that the two major protein fractions of rat urine constitute different forms of the same parent protein, alpha(2u)-globulin, having no amino-acid sequence resemblance to prealbumin (transthyretin) of rat serum.
Collapse
Affiliation(s)
- C Bayard
- Division of Respiratory Allergy and Immunology, National Institute for Working Life, Solna, Sweden
| | | | | |
Collapse
|
26
|
Abstract
For protein quantitation in gels or blotting membranes, chemiluminescence (CL) offers the advantages of a substantial improvement of detection limits. Easy-to-use CL-chemicals and specific probes such as antibodies conjugated to enzymes, e.g. alkaline phosphatase (AP) may be used in combination with a newly developed luminometer. CL was found to have low detection limits and a linear relation between relative light units (RLU) and the concentration of the antibody enzyme complex present over a wide concentration range. Measurements of the immunoglobulin IgE in dot blots and in blots after sodium dodecyl sulfate (SDS) electrophoresis under nonreducing conditions in agarose gels are described.
Collapse
Affiliation(s)
- O Vesterberg
- Division of Respiratory Allergology and Immunology, IMA, National Institute of Occupational Health, Solna, Sweden
| | | | | |
Collapse
|
27
|
Abstract
The proteins of parasympathetically stimulated cat parotid saliva were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and high resolution two-dimensional electrophoresis (2-DE). SDS-PAGE revealed up to 30 polypeptide bands in microliter volumes of unconcentrated saliva. The patterns were highly reproducible and characterized by prominent bands of M(r) 57,000, M(r) 30,000 and M(r) 15,000. The major protein (M(r) 30,000) appeared as a dimer (M(r) 60,000) when electrophoresed under non-reducing conditions but dissociated into its monomeric form when the SDS concentration of the denatured samples was increased from 1 to 5%. This indicates a noncovalent association. The protein patterns of saliva from different cats differed slightly but sequential samples from the same cat (collected during 90 min of stimulation) showed little change in protein pattern apart from a fall in total protein content. Following 2-DE, the major protein (M(r) 30,000) appeared as a complex array of at least eight spots in two tiers (pI 5.2-6.2; M(r) 28,000 and 32,000). The characteristics of this protein are discussed with reference to allergy to cats.
Collapse
Affiliation(s)
- T Marshall
- School of Health Sciences, University of Sunderland, Great Britain
| | | | | | | | | | | |
Collapse
|
28
|
Affiliation(s)
- T Marshall
- School of Health Sciences, University of Sunderland, U.K
| | | | | | | | | | | |
Collapse
|
29
|
Williams KM, Marshall T, Ekstrom J, Tobin G, Bayard C, Vesterberg O. Effects of atropine upon the secretion of rate parotid salivary proteins. Biochem Soc Trans 1993; 21:196S. [PMID: 8359449 DOI: 10.1042/bst021196s] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Affiliation(s)
- K M Williams
- School of the Environment and Health Sciences, University of Sunderland, U.K
| | | | | | | | | | | |
Collapse
|
30
|
Marshall T, Williams KM, Bayard C, Vesterberg O. High resolution two-dimensional electrophoresis of the rat urinary alpha 2u-globulin fraction indicates further purification by ultrafiltration. Biochem Soc Trans 1992; 20:188S. [PMID: 1383054 DOI: 10.1042/bst020188s] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Affiliation(s)
- T Marshall
- School of Pharmaceutical & Chemical Sciences, Sunderland Polytechnic, U.K
| | | | | | | |
Collapse
|
31
|
Marshall T, Williams KM, Bayard C, Vesterberg O. Fractionation of rat urinary proteins by sequential ultrafiltration. Biochem Soc Trans 1992; 20:187S. [PMID: 1397567 DOI: 10.1042/bst020187s] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Affiliation(s)
- T Marshall
- School of Pharmaceutical & Chemical Sciences, Sunderland Polytechnic, U.K
| | | | | | | |
Collapse
|
32
|
Marshall T, Williams KM, Bayard C, Vesterberg O. Isolation of rat urinary alpha 2-euglobulin: a comparison of exhaustive dialysis versus Centriprep ultrafiltration. Biochem Soc Trans 1992; 20:39S. [PMID: 1378799 DOI: 10.1042/bst020039s] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Affiliation(s)
- T Marshall
- Biochemistry Research Laboratory, School of Pharmaceutical & Chemical Sciences, Sunderland Polytechnic, U.K
| | | | | | | |
Collapse
|
33
|
Bayard C. [Geriatric activities in Valais (Sion region). Status and reflections]. Rev Med Suisse Romande 1987; 107:229-34. [PMID: 3589314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
|